v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Cash flows from operating activities:      
Net income (loss) $ (3,519,440) $ 501,728  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation expense 92,193 104,825  
Amortization of intangible assets 46,119 41,823  
Amortization of deferred license costs 10,196 10,196  
Amortization of debt issuance costs and debt discount 169,040 8,628  
Amortization of right of use asset 230,690 109,308  
Common stock issued for services 437,325  
Bad debt expense 7,024  
Interest income on long-term note receivable (9,247) (9,247)  
Stock-based compensation 656,369 649,090  
Loss on asset disposal 241  
Changes in operating assets and liabilities:      
Accounts receivable 268,284 486,117  
Contract assets (864,333) (91,479)  
Inventories 452,571 219,483  
Prepaid expenses and other current assets (522,314) (128,592)  
Intangible assets (81,180)  
Accounts payable and accrued expenses 1,691,992 (2,052,971)  
Contract liabilities (93,142) 3,768,133  
Due to affiliates (264,451)  
Lease liability (343,808) (102,829)  
Net cash used in operating activities (1,378,685) 3,257,027  
Cash flows from investing activities:      
Purchase of property, plant and equipment (531,083) (922,865)  
Proceeds from sale of equipment 760  
Repayment of promissory note (100,000)  
Project Development Costs (82,265) (338,885)  
Investment in and advances to equity affiliates (25,000)  
Investment in non-marketable securities (500,000)  
Net cash used in investing activities (638,348) (1,860,990)  
Cash flows from financing activities:      
Repayment of short term notes payable (2,500,000)  
Proceeds from short-term notes payable and warrants 5,433,175  
Distribution paid to non-controlling interest (46,417) (1,274,000)  
Net cash provided by (used in) financing activities 2,886,758 (1,274,000)  
Net increase in cash and cash equivalents 869,725 122,037  
Cash and cash equivalents - beginning of period 582,776 13,024,381 $ 13,024,381
Cash and cash equivalents - end of period $ 1,452,501 $ 13,146,418 $ 582,776

Source

HTML PDF
XBRL
ZIP